Clinical Trial

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to characterize current treatment patterns and clinical outcomes among newly diagnosed GEP-NET patients in the United States using open-source Longitudinal Prescription Claims (LRx) and Patient Centric Medical Claims (Dx) databases supplemented with mortality data.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-07
Trial Details
NCT Number NCT07635316
Lead Sponsor Novartis Pharmaceuticals
Conditions Gastroenteropancreatic Neuroendocrine Tumor
Enrollment 4,023 participants
Start Date 2026-06-12
Primary Completion 2027-02-25 (estimated)
Study Completion 2027-02-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-06